| [1] |
NCI.Director's challenge:toward a molecular classification of tumors.http://grauts.nih.gov/grauts/guide/rfa files/RFA-CA-98-027.html.
|
| [2] |
Perou C M,Sorlie T,Eisen M B,et al.Molecular portraits of human breast tumors.Nature,2000,406:747-752.
|
| [3] |
Dalgin G S,Alexe G,Scanfeld D,et al.Portraits of breast cancer progression.Bioinformatics,2007,8:291.
|
| [4] |
Hu Z,Fan C,Oh D S,et al.The molecular portraits of breast tumors are conserved across microarray platforms.BMC Genomics,2006,7:96.
|
| [5] |
Liu H,Fan Q,Zhang Z,et al.Basal-HER-2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.Hum Pathol,2008,39:167-174.
|
| [6] |
Badve S,Turbin D,Thorat M A,et al.FOXA1 expression in breast cancer-correlation with luminal subtype A and survival.Clin Cancer Res,2007,13:4415-4421.
|
| [7] |
Sorlie T.Molecular portraits of breast cancer:tumour subtypes as distinct disease entities.Eur J Cancer,2004,40:2667-2675.
|
| [8] |
whitfield M L,Sherlock G,Saldanha A J,et al.Identification of genes periodically expressed in the human cell cycle and their expression in tumors.Mol Biol Cell,2002,13:1977-2000.
|
| [9] |
Böcker W,Moll R,Poremba C,et al.Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages:a new cell biological concept.Lab Invest,2002,82:737-746.
|
| [10] |
Böcker W,Buerger H.Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium:a new progenitor(adult stem)cell concept.Cell Prolif,2003,36:73-84.
|
| [11] |
Stingl J,Eaves C J,Zandieh I,et al.Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue.Breast Cancer Res Treat,2001,67:93-109.
|
| [12] |
Dontu G,Abdallah W M,Foley J M,et al.In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.Genes Dev,2003,17:1253-1270.
|
| [13] |
Dontu G,Al Hajj M,Abdallah W M,et al.Stem cells in normal breast development and breast cancer.Cell Prolif,2003,36:59-72.
|
| [14] |
Birnbaum D,Bertucci F,Ginestier C,et al.Basal and luminal breast cancers:basic or luminous?Int J Oncol,2004,25:249-258.
|
| [15] |
Livasy C A,Karaca G,Nanda R,et al.Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.Mod Pathol,2006,19:264-271.
|
| [16] |
Rodríguez Pinilla S M,SarrióD,Honrado E,et al.Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.J Clin Pathol,2007,60:1006-1012.
|
| [17] |
Matos I,Dufloth R,Alvarenga M,et al.p63,cytokeratin 5,and P-cadherin:three molecular markers to distinguish basal phenotype in breast carcinomas.Virchows Arch,2005,447:688-694.
|
| [18] |
korsching E,Packeisen J,Agelopoulos K,et al.Cytogenetic alterations and cytokeratin expression patterns in breast cancer:integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis.Lab Invest,2002,82:1525-1533.
|
| [19] |
Wang Z C,Lin M,Wei L J,et al.Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers.Cancer Res,2004,64:64-71.
|
| [20] |
Kim M J,Ro J Y,Ahn S H,et al.Clinicopathologic significance of the basal-like subtype of breast cancer:a comparison with hormone receptor and HER-2/neu-overexpression phenotype.Hum Pathol,2006,37:1217-1226.
|
| [21] |
Ihemelandu C U,Leffall L D,Dewitty R L,et al.Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women:age-specific prevalence and survival.J Surg Res,2007,143:109-118.
|
| [22] |
Millikan R C,Newman B,Tse C K,et al.Epidemiology of basal-like breast cancer.Breast Cancer Res Treat,2008,109:123-129.
|
| [23] |
Sorlie T,Tibshirani R,Parker J,et al.Repeated observation of breast tumor subtypes in independent gene expression data sets.Proc Natl Acad Sci USA,2003,100:8418-8423.
|
| [24] |
Sotiriou C,Neo S Y,Mcshane L M,et al.Breast cancer classification and prognosis based on gene expression profiles from a population-based study.Proc Natl Acad Sci USA ,2003,100:10 393-10 398.
|
| [25] |
Charafe Jauffret E,Ginestier C,Monville F,et al.How to best classify breast cancer:conventional and novel classification.Int J Oncol,2005,27:1307-1313.
|
| [26] |
Fulford L G,Easton D F,Reis Filho J S,et al.Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.Histopathology,2006,49:22-34.
|
| [27] |
Rakha E A,Putti T C,Abd El Rehim D M ,et al.Morpholo-gical and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.J Pathol,2006,208:495-506.
|
| [28] |
Carey L A,Dees E C,Sawyer L,et al.The triple negative paradox:primary tumor chemosensitivity of breast cancer subtypes.Clin Cancer Res,2007,13:2329-2334.
|
| [29] |
Rakha E A,El Rehim D A,Paish C,et al.Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.Eur J Cancer,2006,42:3149-3156.
|
| [30] |
Rakha E A,El Sayed M E,Green A R,et al.Prognostic markers in triple-negative breast cancer.Cancer,2007,109:25-32.
|
| [31] |
Rouzier R,Perou C M,Symmans W F,et al.Breast cancer molecular subtypes respond differently to preoperative chemotherapy.Clin Cancer Res,2005,11:5678-5685.
|
| [32] |
王哲海.HER-2过表达对乳腺癌治疗策略的影响.中华乳腺病杂志:电子版,2008,2:88-102.
|